Profit From The “Urge To Merge” In The Diagnostics Space

On the heels of the news of Roche acquiring GenMark Diagnostics, the author of today’s article shares two more leading diagnostics companies that he believes are prime COVID-19 takeover targets – and advises that “there’s definitely a chance to earn a quick 50% to 100% if you act fast.” For these two companies that could offer ways to profit from a continued “urge to merge” in the diagnostics space, CLICK HERE.